Chairs

  • Emily Breidbart
  • Sowmya Krishnan

BOD Liaison

Laurie Cohen

Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.

LUPRON DEPOT-PED 45 mg for 6 months
January 31, 2024

LUPRON DEPOT-PED 45 mg for 6 months Prepared and edited…

Levemir®, Discontinued
November 27, 2023

Novo Nordisk announced on 11/8/2023 that their long-acting insulin, Levemir®, will…

New Drugs and Therapeutics Update – NGENLA
November 8, 2023

New Drugs and Therapeutics Update – NGENLA By Dania Al-Hamad,…